These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1429337)

  • 1. Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes.
    Scheffer J; Knöller J; Cullmann W; König W
    J Antimicrob Chemother; 1992 Jul; 30(1):57-66. PubMed ID: 1429337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephalosporins and inflammatory host reactions.
    Scheffer J; König W
    Respiration; 1993; 60 Suppl 1():25-31. PubMed ID: 7683137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of human granulocytes and monocytes on the antibacterial activity of cefetamet against Staphylococcus aureus.
    van den Broeck PJ; Seymonsbergen EM
    J Antimicrob Chemother; 1995 May; 35(5):611-22. PubMed ID: 7592174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of cefetamet (RO 15-8074).
    Machka K; Braveny I
    Eur J Clin Microbiol; 1987 Aug; 6(4):496-7. PubMed ID: 3478193
    [No Abstract]   [Full Text] [Related]  

  • 6. The in-vitro influence of ceftazidime on host defence mechanisms.
    Gnarpe H; Belsheim J; Blomqvist C; Lundbäck A; Svensson AC
    J Antimicrob Chemother; 1984 Apr; 13(4):369-75. PubMed ID: 6427174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of RO 15-8074 and RO 19-5247.
    Valle T; Jalanko E; Scheinin L; Renkonen OV
    Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cefpodoxime on selected immunological functions and bacterial pathogenicity factors in vitro.
    Schubert S; Ullmann U
    Zentralbl Bakteriol; 1991 Jun; 275(2):233-40. PubMed ID: 1930575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of cefetamet (Ro 15-8074) compared with other oral agents.
    Rozgonyi F; Papp-Falusi E; Varga J; Rozgonyi-Szitha K
    J Antimicrob Chemother; 1989 Oct; 24(4):539-46. PubMed ID: 2613603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of Ro-15-8074, a new oral cephalosporin.
    Peeters M; Piot P
    J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an immunostimulatory substance of Klebsiella pneumoniae on inflammatory responses of human granulocytes, basophils and platelets.
    Scheffer J; Ounis I; König W
    Arzneimittelforschung; 1991 Aug; 41(8):815-20. PubMed ID: 1723598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro effects of ceftibuten on the host defense mechanism.
    Braga PC; Piatti G; Dal Sasso M; Maci S; Blasi F
    Chemotherapy; 1994; 40(1):37-41. PubMed ID: 8306814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.
    Ng WS; Chau PY; Leung YK; Wong PC
    Antimicrob Agents Chemother; 1985 Sep; 28(3):461-3. PubMed ID: 3935045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
    Chau PY; Leung YK; Ng WW; Arnold K
    Antimicrob Agents Chemother; 1987 Mar; 31(3):473-6. PubMed ID: 3579264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desirable and undesirable immunotropic effects of antibiotics: immunomodulating properties of cefaclor.
    Dabrowski MP; Stankiewicz W
    J Chemother; 2001 Dec; 13(6):615-20. PubMed ID: 11806622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of subinhibitory concentrations of cefaclor, erythromycin and doxycycline on phagocytosis and intracellular killing of E. coli by human neutrophil granulocytes].
    Stübner G
    Arzneimittelforschung; 1986 Nov; 36(11):1702-4. PubMed ID: 3545226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced susceptibility of Staphylococcus aureus pretreated with cefepime and cefpodoxime to leukocyte activity.
    Herrera I; Martinez P; Perez P; Garcia Y; Gomez-Lus ML; Prieto J
    J Chemother; 1995 Nov; 7 Suppl 4():23-5. PubMed ID: 8904094
    [No Abstract]   [Full Text] [Related]  

  • 19. Cefetamet pivoxil: comparable evaluation with other orally available antibiotics against selected species of respiratory pathogens.
    Speciale A; Caccamo F; Blandino G; Giacchi GT; Aleo G; Nicoletti G
    Chemotherapy; 1996; 42(1):1-10. PubMed ID: 8751262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.